292 related articles for article (PubMed ID: 8413410)
21. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
23. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
24. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment.
Yamada M; Wasserman R; Lange B; Reichard BA; Womer RB; Rovera G
N Engl J Med; 1990 Aug; 323(7):448-55. PubMed ID: 2095753
[TBL] [Abstract][Full Text] [Related]
25. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias.
Consolini R; Scamardella F; Legitimo A; Putti C; Granchi D; Paolucci P; Lippi A; Guazzelli C; Acquaviva A; Rosanda C
Haematologica; 1993; 78(5):297-305. PubMed ID: 8314159
[TBL] [Abstract][Full Text] [Related]
28. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
[TBL] [Abstract][Full Text] [Related]
30. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].
Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W
Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071
[TBL] [Abstract][Full Text] [Related]
31. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
[TBL] [Abstract][Full Text] [Related]
32. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
[TBL] [Abstract][Full Text] [Related]
33. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
[TBL] [Abstract][Full Text] [Related]
34. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse.
Biondi A; Yokota S; Hansen-Hagge TE; Rossi V; Giudici G; Maglia O; Basso G; Tell C; Masera G; Bartram CR
Leukemia; 1992 Apr; 6(4):282-8. PubMed ID: 1316978
[TBL] [Abstract][Full Text] [Related]
35. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia.
Löwenberg B; van Putten WL; Touw IP; Delwel R; Santini V
N Engl J Med; 1993 Mar; 328(9):614-9. PubMed ID: 8429853
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Willoughby M
Leuk Lymphoma; 2001 Jan; 40(3-4):279-85. PubMed ID: 11426549
[TBL] [Abstract][Full Text] [Related]
37. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.
Sievers EL; Lange BJ; Buckley JD; Smith FO; Wells DA; Daigneault-Creech CA; Shults KE; Bernstein ID; Loken MR
J Natl Cancer Inst; 1996 Oct; 88(20):1483-8. PubMed ID: 8841024
[TBL] [Abstract][Full Text] [Related]
38. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
Estrov Z; Grunberger T; Dubé ID; Wang YP; Freedman MH
N Engl J Med; 1986 Aug; 315(9):538-42. PubMed ID: 3488505
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.
Uckun FM; Kersey JH; Vallera DA; Ledbetter JA; Weisdorf D; Myers DE; Haake R; Ramsay NK
Blood; 1990 Nov; 76(9):1723-33. PubMed ID: 2224122
[TBL] [Abstract][Full Text] [Related]
40. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia.
Estrov Z; Ouspenskaia MV; Felix EA; McClain KL; Lee MS; Harris D; Pinkel DP; Zipf TF
Leukemia; 1994 Jan; 8(1):46-52. PubMed ID: 8289497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
